Implementation of the Patient Protection and Affordable Care Act is largely good news for patients with HIV, many of whom have been denied coverage under preexisting condition clauses. However, some questions and some gaps in coverage remain to be addressed.
When the FDA approved pre-exposure prophylaxis for HIV prevention, observers wondered whether or not the strategy was cost effective. A study has now analyzed the question. Answer: It depends.
(AUDIO) How often should people be (re)tested for HIV? A pair of industrial efficiency experts looked at current HIV testing recommendations, and found them too conservative.
(AUDIO) For older as well as young patients, clinicians should be sure to test regularly for HIV as the CDC advises, says a researcher who tells in this interview how suspicions about the origin of AIDS and the involvement of government may discourage older people from being tested.
Cardiovascular disease is now the cause of death for 10% of HIV-positive patients. Why this happens and how to prevent or treat it remain unclear, but research presented at the CROI conference offers insights into potential solutions.
From remote villages in Kenya to large cities in the United States, mobile phones and smart phones are becoming tools to overcome some of the greatest challenges in HIV—prevention, screening, and treatment adherence.
Hospitals, clinics, and researchers are investigating how electronic health records and personal health records, portals that give patients access to records and health education, can be used to improve HIV screening and outcomes.
(AUDIO) Correctional institutions offer an excellent opportunity to discover and treat HIV infection, which is usually contracted before incarceration. How can physicians assure that care is just as good after these patients are released into the community?
Top recent reports in HIV/AIDS research include a better way to deliver a vaccine in developing countries, a more effective way to administer a preventive drug, and insights into the cause of neurocognitive deficits.
Studies in Africa have shown that a new strain of the HIV virus leads to more rapid progression than previous strains, and other research suggests that in general HIV is becoming more aggressive. What does this mean for control of transmission?
Organizations from the Centers for Disease Control and Prevention (CDC) to the World Health Organization are looking for ways to engage adults and teenagers online in discussions about HIV prevention, testing, and treatment.
Nearly a fourth of new HIV infections are among adolescents or people in their early 20s. An adolescent AIDS expert tells how their management should differ from that of adult patients infected with HIV.
Are some of your HIV-positive patients non-adherent to their ART therapy? Consider a carefully planned conversation about their drinking habits.
Finding a plethora of federal recommendations on managing illicit drug-use behaviors and sexually transmitted infections including HIV, the Centers for Disease Control and Prevention has weighed in on organized management of these health issues that often coincide.
(AUDIO) US Preventive Services Task Force recommendations for HIV screening may come into line with CDC guidelines thanks to a reanalysis of recent outcomes data. Here clinical epidemiologist Roger Chou MD, who conducted the analysis, describes the new evidence and the implications.